San Diego, CA, United States of America

Kirk B Nielson

This inventor holds 4 USPTO granted patents. Top assignee: Stratagene. Active years: 1995-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kirk B Nielson. Retrieved from https://idiyas.com/inventor/kirk-b-nielson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 87(Granted Patents)


Company Filing History:


Years Active: 1995-1998

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kirk B Nielson: Innovator in Nucleic Acid Technology

Introduction

Kirk B Nielson is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of nucleic acid technology, holding a total of four patents. His work focuses on improving methods for producing primed nucleic acid templates, which are essential in various biotechnological applications.

Latest Patents

One of his latest patents is titled "Method for producing primed nucleic acid templates." This invention relates to an improved method for producing these templates, specifically enhancing the specificity of primer extension reactions. The method involves hybridizing a primer to a template in the presence of single-stranded nucleic acid binding protein, which increases the efficiency and accuracy of the process.

Career Highlights

Kirk B Nielson has been associated with Stratagene, a company known for its innovative solutions in molecular biology. His work at Stratagene has allowed him to develop and refine techniques that are widely used in research and clinical settings.

Collaborations

Kirk has collaborated with Eric J Mathur, contributing to advancements in their field through shared expertise and innovative ideas.

Conclusion

Kirk B Nielson's contributions to nucleic acid technology have made a significant impact on the industry. His innovative methods and patents continue to influence research and development in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…